Patterns, predictors and preventability of adverse drug reactions in the coronary care unit of a tertiary care hospital

European Journal of Clinical Pharmacology

Volumn 68, Issue 4, 2012, Pages 427-433

  Devi, Padmini ^a   Kamath, Deepak Y ^a   Anthony, Naveen ^a   Santosh, Sushma ^a   Dias, Brendan ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Adverse drug reactions; Coronary care unit; Polypharmacy; Streptokinase

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; AMLODIPINE; CARVEDILOL; CLOPIDOGREL; CYCLOSPORIN; DIGOXIN; EPTIFIBATIDE; FLUCONAZOLE; FUROSEMIDE; GLIBENCLAMIDE; GLIBENCLAMIDE PLUS METFORMIN; GLIMEPIRIDE; GLYCERYL TRINITRATE; HEPARIN; INSULIN; LOSARTAN; METOPROLOL; NICORANDIL; NONSTEROID ANTIINFLAMMATORY AGENT; OXANDROLONE; PREDNISOLONE; RAMIPRIL; SALBUTAMOL; SPIRONOLACTONE; STREPTOKINASE; TERBUTALINE; WARFARIN;

ACUTE KIDNEY FAILURE; ADULT; ADVERSE DRUG REACTION; ARTICLE; BLEEDING; BRADYCARDIA; BRAIN HEMORRHAGE; CHI SQUARE TEST; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY CARE UNIT; DISEASE SEVERITY; FEMALE; GASTRITIS; HEART ARRHYTHMIA; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE HYPERTROPHY; HOSPITALIZATION; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOKALEMIA; HYPOTENSION; INDEPENDENT T TEST; INTERNATIONAL NORMALIZED RATIO; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYPHARMACY; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; STATISTICAL ANALYSIS; SUPRAVENTRICULAR TACHYCARDIA; TERTIARY HEALTH CARE; UREMIA;

ADULT; AGED; COHORT STUDIES; CORONARY CARE UNITS; DRUG TOXICITY; FEMALE; HOSPITALS, TEACHING; HUMANS; INDIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84860263577     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1138-9     Document Type: Article

References (19)

1. Krahenbuhl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krahenbuhl S (2007) Drug-related problems in hospitals: a review of the recent literature. Drug Saf 30(5):379-407 (Pubitemid 46740336)
2. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279(15):1200-1205 (Pubitemid 28193431)
3. Wester K, Jonsson AK, Spigset O, Druid H, Hagg S (2008) Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 65(4):573-579 (Pubitemid 351365134)
4. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA et al (1997) The costs of adverse drug events in hospitalized patients. Adverse drug events prevention study group. JAMA 277 (4):307-311 (Pubitemid 27045011)
5. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 277(4):301-306 (Pubitemid 27045010)
6. Wroblewski HA, Tisdale JE, Overhaolser BR, Joanna R. Adverse drug events resulting in admissions to a cardiac care unit. J Am Coll Cardiol 2010;(55).
7. Davies EC, Green CF, Mottram DR, Pirmohamed M (2007) Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2(1):79-87 (Pubitemid 46723172)
8. Mohebbi N, Shalviri G, Salarifar M, Salamzadeh J, Gholami K (2010) Adverse drug reactions induced by cardiovascular drugs in cardiovascular care unit patients. Pharmacoepidemiol Drug Saf 19 (9):889-894
9. World Health Organization (1972) International drug monitoring -the role of national centers. Technical Report No. 498. World Health Organization, Geneva
10. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30(2):239-245 (Pubitemid 12149145)
11. Schumock GT, Thornton JP (1992) Focusing on the preventability of adverse drug reactions. Hosp Pharm 27(6):538
12. Hartwig SC, Siegel J, Schneider PJ (1992) Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 49(9):2229-2232
13. Fahimi F, Baniasadi S (2008) Adverse drug reactions in the post coronary care unit inpatients of a teaching hospital. Iranian J Pharm Res 7:223-228
14. Joshua L, Devi P, Guido S (2009) Adverse drug reactions in medical intensive care unit of a tertiary care hospital. Pharmacoepidemiol Drug Saf 18(7):639-645
15. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D et al (1995) Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE prevention study group. JAMA 274(1):29-34
16. Winterstein AG, Sauer BC, Hepler CD, Poole C (2002) Preventable drug-related hospital admissions. Ann Pharmacother 36(7-8):1238-1248 (Pubitemid 34755803)
17. Routledge PA, O'Mahony MS, Woodhouse KW (2003) Adverse drug reactions in elderly patients. Br J Clin Pharmacol 57:121-126
18. Venulet J, ten Harn M (1996) Methods for monitoring and documenting adverse drug reactions. Int J Clin Pharmacol Ther 34 (3):112-129
19. Rahim SA, Mody A, Pickering J, Devereaux PJ, Yusuf S (2010) Iatrogenic adverse events in the coronary care unit. Circ Cardiovasc Qual Outcomes 2:437-442